Home/Filings/4/0001493152-23-032372
4//SEC Filing

Hsu Jason 4

Accession 0001493152-23-032372

CIK 0001873835other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:58 PM ET

Size

6.8 KB

Accession

0001493152-23-032372

Insider Transaction Report

Form 4
Period: 2023-09-08
Hsu Jason
Director
Transactions
  • Purchase

    Common Stock

    2023-09-08$2.53/sh+10,000$25,317685,000 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    3,915,913
  • Common Stock

    (indirect: See Footnote)
    50,000
Footnotes (3)
  • [F1]This figure is the weighted average sales price of multiple trades ranging from $2.51 to $2.559 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.
  • [F2]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
  • [F3]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001895035

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:58 PM ET
Size
6.8 KB